Northwest Neurology, Ltd. is a leading private practice group in Illinois, specializing in a wide range of neurological care since 1983. With a team of providers who have received training from prestigious academic medical centers, the company offers expertise in subspecialties such as dementia, headache/migraine, movement disorders, multiple sclerosis, and more. Operating from eight outpatient locations, they deliver comprehensive diagnostics including MRI, EEG, EMG, and sleep studies. Moreover, they provide advanced treatments such as Botulinum Toxin therapy for migraine and infusion therapy for neurological and non-neurological disorders.
As a prime player in the healthcare industry, Northwest Neurology is positioned strongly to capitalize on the increasing demand for specialized neurological care. Currently, there is no available information regarding their recent investments or potential investors. Nevertheless, their longstanding presence and multifaceted service offerings position them as an attractive prospect for potential venture capital interest.
There is no investment information
No recent news or press coverage available for Northwest Neurology, Ltd..